Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Evaluation of brain perfusion SPECT imaging using 99mTc-ECD].

H Matsuda1, K Kinuya, S Higashi

  • 1Department of Nuclear Medicine, Kanazawa University School of Medicine.

Kaku Igaku. the Japanese Journal of Nuclear Medicine
|July 1, 1991
PubMed
Summary

Technetium-99m ethyl cysteinate dimer (99mTc-ECD) is a promising brain perfusion SPECT agent with good stability and brain uptake. Optimal imaging is recommended around 1 hour postinjection for improved contrast.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purification and characterization of a novel growth factor (FF-GF) synthesized by a rat hepatoma cell line, FF101.

Biochemical and biophysical research communications·1992
Same author

Hyperthermo-chemo-radiotherapy as a definitive treatment for patients with early esophageal carcinoma.

American journal of clinical oncology·1992
Same author

The 11q- syndrome with mosaic partial deletion of 11q.

Acta paediatrica Japonica : Overseas edition·1992
Same author

[Basic and clinical studies on cefprozil in pediatrics].

The Japanese journal of antibiotics·1992
Same author

Preoperative hyperthermia combined with chemotherapy and radiotherapy for patients with rectal carcinoma may prevent early local pelvic recurrence.

International journal of colorectal disease·1992
Same author

Effect of intra-aortic balloon pumping after cardiac surgery: comparative study of use in coronary bypass and valve replacement.

The Kobe journal of medical sciences·1992

Area of Science:

  • Nuclear Medicine
  • Radiopharmacology
  • Neuroimaging

Background:

  • Brain perfusion imaging is crucial for diagnosing neurological disorders.
  • Technetium-99m ethyl cysteinate dimer (99mTc-ECD) is a novel agent for assessing cerebral blood flow.
  • Evaluating its performance is essential for clinical application.

Purpose of the Study:

  • To conduct a fundamental and clinical evaluation of 99mTc-ECD for brain perfusion SPECT.
  • To determine the optimal timing for imaging with 99mTc-ECD.

Main Methods:

  • Radiochemical purity and stability of 99mTc-ECD were assessed.
  • Biodistribution studies were performed in animal models.
  • Brain uptake, washout kinetics, and distribution patterns were analyzed.

Related Experiment Videos

  • Comparative imaging studies with 99mTc-IMP and 99mTc-HMPAO were conducted.

    • Main Results:

    • 99mTc-ECD demonstrated high radiochemical purity (>98%) and stability up to 24 hours.
    • The agent showed significant brain uptake (approx. 5% injected dose) with slow washout (5.6%/hr).
    • Optimal brain distribution and contrast were observed around 1 hour postinjection, with extracranial clearance and improved lesion detectability in certain areas (striatal, thalamic).

    Conclusions:

    • 99mTc-ECD is a stable and effective agent for brain perfusion SPECT.
    • Imaging at approximately 1 hour postinjection is recommended for better diagnostic accuracy.
    • Its performance in lesion detection varies compared to other agents like 99mTc-IMP and 99mTc-HMPAO.